The global neurovascular devices market size reached US$ 2.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.12% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Neurovascular devices, also known as interventional neurology devices, are used to treat neurovascular disorders, such as ischemic stroke aneurysms, stenosis, arteriovenous malformation, and fistulas. They include embolic coils, liquid embolic agents, flow diversion devices, arterial stents, catheters, and guidewires. They allow physicians to gain endovascular access to the treatment areas in the brain and provide efficient treatment. As a result, they are gaining immense traction in the healthcare industry and are extensively used in the treatment and diagnosis of numerous peripheral and central nervous system disorders and ailments.

Neurovascular Devices Market Trends:
The growing global geriatric population, which is highly susceptible to acquiring these disorders, represents one of the key factors positively influencing the market. These disorders cause moderate to severe damage to the brain, resulting in conditions like strokes and cerebral hemorrhage. This, along with the rising lifestyle disorders, such as obesity, is catalyzing the demand for neurovascular devices across the globe. In addition, rapid urbanization, sedentary lifestyles, and stress are resulting in rising incidences of stroke, which, in turn, is increasing the need for neurovascular devices. The rising awareness among patients about the easy availability of treatment and reimbursement for neurological disorders is increasing the adoption of these devices and strengthening the growth of the market. Furthermore, technological advancements in neurovascular treatments and government initiatives to modernize healthcare infrastructure across the globe are offering a favorable market outlook. Additionally, various initiatives are being undertaken by governments of various countries to generate awareness among the general population about symptoms and measures to be taken in case of emergency and available treatment options. Moreover, rapid expansion of hospitals and surgical centers, ambulatory care centers, research laboratories, and academic institutes is increasing the requirement for neurovascular devices worldwide.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurovascular devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Cerebral Embolization and Aneurysm Coiling Devices
Embolic Coils
Flow Diverters
Liquid Embolic Agents
Cerebral Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Devices
Neurothrombectomy Devices
Clot Retrieval Devices
Suction Devices
Vascular Snares
Support Devices
Micro Catheters
Micro Guidewires

Breakup by Application:

Ischemic Stroke
Aneurysm
Arteriovenous Malformation and Fistulas (AVM)
Stenosis
Others

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Clinics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acandis GmbH, Asahi Intecc Co. Ltd., Imperative Care Inc., Integer Holdings Corporation, Johnson & Johnson, Medtronic plc, MicroPort Scientific Corporation, Penumbra Inc., Perflow Medical Ltd., Rapid Medical, Stryker Corporation and Terumo Corporation.

Key questions answered in this report:
How has the global neurovascular devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neurovascular devices market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurovascular devices market and who are the key players?
What is the degree of competition in the industry?